The ATR DDR pathway is critical for duplicating DNA under stressful conditions (Saldivar et al., 2017), and ATR inhibitors as either monotherapy or combination therapy have been in different phases of clinical trials of cancer patients (Karnitz and Zou, 2015; Bradbury et al., 2020). Here, ATR is linked to cancer.